Zobrazeno 1 - 10
of 55
pro vyhledávání: '"S. R. Poort"'
Autor:
A. Sturk, J. Stibbe, E. B. Gómez García, M. Kappers, Rogier M. Bertina, S. R. Poort, M. C. L. Schaap
Publikováno v:
British Journal of Haematology. 112:513-518
Congenital factor XIII (FXIII) deficiency is a rare autosomal recessive disorder, usually attributed to a defect in the FXIII A subunit, whose genetic basis has been studied in a number of cases. We describe here the genetic variations found in two u
Factor X Levels, Polymorphisms in the Promoter Region of Factor X, and the Risk of Venous Thrombosis
Publikováno v:
Thrombosis and Haemostasis. 85:1011-1017
SummaryElevated levels of procoagulant proteins factor II, factor VIII, factor IX, factor XI and fibrinogen are associated with an increased risk of venous thrombosis. In a population-based case-control study on venous thrombosis (Leiden Thrombophili
Autor:
Parichat Pung-Amritt, S R Poort, Mahasandana C, Gavivann Veerakul, Hans L. Vos, Vinai Suvatte, Rogier M. Bertina, Voravarn S. Tanphaichitr, Suthida Kankirawatana
Publikováno v:
Thrombosis and Haemostasis. 81:189-192
SummaryHomozygous or compound heterozygous protein S (PS) deficiency is a very rare disorder in the anticoagulant system, that can lead to life-threatening thrombotic complications shortly after birth. This report describes the results of the genetic
Two novel mutations in the prothrombin gene cause severe bleeding in a compound heterozygous patient
Publikováno v:
Blood Coagulation & Fibrinolysis. 9:761-769
Hypoprothrombinemia is a rare hereditary coagulation defect characterized by low levels of biologically active prothrombin. In this paper we report the laboratory and genetic analysis of a patient with a severe hypoprothrombinemia and some of her rel
Publikováno v:
Blood. 88:3698-3703
We have examined the prothrombin gene as a candidate gene for venous thrombosis in selected patients with a documented familial history of venous thrombophilia. All the exons and the 5′- and 3′-UT region of the prothrombin gene were analyzed by p
Autor:
Rosemiek Cupers, S R Poort, R M Bertina, E. G. C. Wojcik, M. Van Den Berg, I K van der Linden
Publikováno v:
Biochemical Journal. 311:753-759
Factor IX Zutphen is a variant factor IX molecule isolated from the blood of a patient with severe haemophilia B. The molecular defect in factor IX Zutphen is a Cys18-->Arg mutation as a result of a T-->C transition at residue 6427 of the factor IX g
Autor:
Pieter H. Reitsma, F. J. M. Van Der Meer, Ernest Briët, S R Poort, P. H. Trienekens, Ted Koster, L. P. Colly, Jan P. Vandenbroucke, Frits R. Rosendaal
Publikováno v:
Blood. 85:2756-2761
A deficiency of protein C (PC), antithrombin, or protein S is strongly associated with deep-vein thrombosis in selected patients and their families. However, the strength of the association with venous thrombosis in the general population is unknown.
Autor:
Pieter H. Reitsma, S. I. A. M. Islam, J. A. Conkie, S R Poort, Rogier M. Bertina, Isobel D. Walker, Robert Campbell Tait, Frances McCall
Publikováno v:
Thrombosis and Haemostasis. 73:087-093
SummaryReported prevalence rates for protein C (PC) deficiency in the population at large have varied widely. The differences presumably reflect the existence of an apparently high number of clinically recessive forms of the deficiency. In an attempt
Autor:
P H Reitsma, F Bernardi, R G Doig, S Gandrille, J S Greengard, H Ireland, M Krawczak, B Lind, G L Long, S R Poort, H Saito, N Sala, I Witt, D N Cooper
Publikováno v:
Thrombosis and Haemostasis. 73:876-889
Publikováno v:
Biochemical journal, 302 ( Pt 1), 305-312. Portland Press Ltd.
Annexin V binds with high affinity to procoagulant phospholipid vesicles and thereby inhibits the procoagulant reactions catalysed by these surfaces in vitro. In vivo, vascular endothelial cells are known to catalyse the formation of thrombin by the